AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.
about
Signal-peptide-mediated translocation is regulated by a p97-AIRAPL complexCaenorhabditis elegans as a model organism to study APP functionIntegrated control of protein degradation in C. elegans muscleGenetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicitySLR-2 and JMJC-1 regulate an evolutionarily conserved stress-response network.skn-1-Dependent and -independent regulation of aip-1 expression following metabolic stress in Caenorhabditis elegans.A cocoa peptide protects Caenorhabditis elegans from oxidative stress and β-amyloid peptide toxicity.Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegansIdentifying Aβ-specific pathogenic mechanisms using a nematode model of Alzheimer's disease.A new role for laminins as modulators of protein toxicity in Caenorhabditis elegans.Selective Binding of AIRAPL Tandem UIMs to Lys48-Linked Tri-Ubiquitin ChainsWhat have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?The ubiquitin proteasome system in Caenorhabditis elegans and its regulation.The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases.Royal jelly promotes DAF-16-mediated proteostasis to tolerate β-amyloid toxicity in C. elegans model of Alzheimer's disease.Neurodegenerative disorders: insights from the nematode Caenorhabditis elegansThe role of protein clearance mechanisms in organismal ageing and age-related diseases.Assaying β-amyloid toxicity using a transgenic C. elegans modelThe Proteasome and Oxidative Stress in Alzheimer's Disease.UPS Activation in the Battle Against Aging and Aggregation-Related Diseases: An Extended Review.Current advances in the functional studies of fatty acids and fatty acid-derived lipids in C. elegansLoss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling.
P2860
Q24338887-B570A0B1-37A1-4188-8C62-3BA34FF6D5ADQ26851244-5F6A5F00-7756-441E-B02B-1B1894E1F810Q26998238-186AF376-512D-4FFC-B47B-041533FD70C9Q28748529-EAE39685-DB60-4777-92CE-AEA225C29E52Q33690581-73EB0246-07BE-46AE-B24B-5447140F7672Q33876975-09C0E3E7-E816-4D70-B4E0-16F4AEC4FC98Q34722805-3E20356D-7EA0-4EB6-B062-CB45A74D7305Q34858502-97AF499F-152B-4F03-AB86-208C469C9C47Q35039312-9702278E-A885-4436-9567-6071AE7F1615Q35044366-DB46C8B6-F2A9-455E-8ED0-EBED5BB79AB6Q35670325-C098829E-7E89-4D8B-88B6-449FD8073801Q36642966-E08282E5-3A30-41EF-AE1A-B1EDD76F4981Q37389590-8BFDBFDC-4C8B-40B0-8B40-AC7FB7D255E0Q37587829-4747109B-84E6-4029-BEEC-242619CB7B95Q37645630-90586B5F-6574-48CC-9475-D3E4B066351CQ37688026-CD44A021-26D8-43A9-9F28-30A55AFB01B0Q37759354-51549749-923D-4ED0-AFA1-FE85A65ED788Q38284376-DA1A64FF-5A8A-4AE1-B73C-62652B625D4EQ38614823-ED33D2FD-6ADE-4594-B56F-16AEC7C038E3Q38843876-31D40B0D-094F-4EF4-AC29-2C3C40CCD464Q38950512-8C3BE549-5F85-4553-81B4-A9D6AFF93601Q38970365-C0CF10BF-1E56-4CFA-8B92-5A9D2BFEE2E1Q50236752-1149EC73-C2B1-43DA-8E57-C58E754987AD
P2860
AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@en
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@nl
type
label
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@en
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@nl
prefLabel
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@en
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@nl
P2093
P2860
P356
P1476
AIP-1 ameliorates beta-amyloid ...... ans Alzheimer's disease model.
@en
P2093
Christopher D Link
David A Merin
Virginia Fonte
P2860
P304
P356
10.1093/HMG/DDP209
P577
2009-05-03T00:00:00Z